4 Largecap Promoter Backed Five-Year Winner Stocks to Watch for Future Multibagger Potential: Sun Pharma, NTPC, Union Bank and Indian Bank

Promoter backed five-year winner stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, NTPC, Union Bank and Indian Bank meet that test, with market caps from Rs 1.14 lakh crore to Rs 4.27 lakh crore and Sun Pharma offering the largest market cap at Rs 4,27,161 crore. Each of these companies has a promoter holding of at least 50 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a promoter holding of at least 50 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening promoter backed five-year winner stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Promoter Backed Five-Year Winner Stocks and Why Do They Attract Multibagger Interest?

Promoter backed five-year winner stocks are shares of large companies in which the promoters own at least half of the business and which have at least doubled investor money over five years, so committed owners have delivered a long record. The four here cover power generation, public sector banking and pharmaceuticals.

Owners with a large stake have their own wealth tied to the company, and a five year record of doubling shows that the business has rewarded shareholders over time. Within promoter backed five-year winner stocks, the four companies show rising profit. For promoter backed five-year winner stocks, both FY26 and the latest quarter showed growth. Whichever way you read promoter backed five-year winner stocks, the common thread is rising profit backed by complete financial data. For promoter backed five-year winner stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of promoter backed five-year winner stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for promoter backed five-year winner stocks before you decide.

Promoter Backed Five-Year Winner Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 30 October 2026. Union Bank has the lowest PE of the group at 6.50, while Indian Bank posts the highest return on equity at 16.02%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Sun Pharmaceutical Industries	1,777.70	4,27,161	35.25	36.42	13.74%	5.11	1,583.70 to 2,046.90
NTPC	316.25	3,18,210	11.23	21.61	13.31%	1.57	298.00 to 414.40
Union Bank of India	186	1,34,103	6.50	12.02	15.57%	1.01	135.80 to 205.49
Indian Bank	865.50	1,13,970	8.62	12.02	16.02%	1.43	756.50 to 1,000.90

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India’s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 35.25 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.

NTPC: Five-Year Gain of 110.40%

NTPC is India’s largest power generation company and is growing its renewable energy portfolio. It reported FY26 revenue of Rs 1,89,798.56 crore and net profit of Rs 30,009.98 crore, up 48.19%. Net profit has compounded at 18.01% a year since FY22, while revenue has grown 8.89% a year. Operating margin was 32.45% in FY26.

The stock trades at a PE of 11.23 against an industry PE of 21.61, below the sector average, with a return on equity of 13.31%. The dividend yield is 2.75%. In the June 2026 quarter, revenue rose 6.94% to Rs 51,141.51 crore and net profit grew 12.90% to Rs 6,896.44 crore. The share price has gained 110.40% over five years. Domestic institutions raised their holding from 28.92% in June 2025 to 29.44% in June 2026.

Union Bank: 37.80% Profit CAGR Since FY22

Union Bank of India is a large government-owned bank that serves retail, MSME and corporate customers across India. It reported FY26 total income of Rs 1,28,399.52 crore, up 0.19% year on year, and net profit of Rs 18,780.63 crore, up 4.80%. Net profit has compounded at 37.80% a year since FY22, while total income has grown 11.95% a year.

In the June 2026 quarter, total income rose 2.17% to Rs 32,660.24 crore and net profit grew 29.77% to Rs 5,368.17 crore. The share price has gained 249.43% over five years and 23.10% over the past year. Foreign investors raised their holding from 7.70% in June 2025 to 8.63% in June 2026. The stock trades at a PE of 6.50 against an industry PE of 12.02, below the sector average, with a return on equity of 15.57%. The dividend yield is 2.85%.

Indian Bank: 32.28% Profit CAGR Since FY22

Indian Bank is a government-owned bank with a strong presence in South India and a growing national network. It reported FY26 total income of Rs 78,332.70 crore, up 8.72% year on year, and net profit of Rs 12,226.99 crore, up 11.21%. Net profit has compounded at 32.28% a year since FY22, while total income has grown 14.07% a year.

The stock trades at a PE of 8.62 against an industry PE of 12.02, below the sector average, with a return on equity of 16.02%. The dividend yield is 2.16%. In the September 2026 quarter, total income rose 21.09% to Rs 23,335.98 crore and net profit grew 13.36% to Rs 3,446.86 crore. The share price has gained 396.82% over five years and 10.47% over the past year. Foreign investors raised their holding from 4.68% in September 2025 to 6.86% in September 2026.

Promoter Backed Five-Year Winner Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these promoter backed five-year winner stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Latest Quarter Revenue Growth
Sun Pharma	61,673.94	11,564.52	11.62%	35.75%	11.93%
NTPC	1,89,798.56	30,009.98	8.89%	18.01%	6.94%
Union Bank	1,28,399.52	18,780.63	11.95%	37.80%	2.17%
Indian Bank	78,332.70	12,226.99	14.07%	32.28%	21.09%

Check the Univest Screener for live data on these promoter backed five-year winner stocks

Institutional Holding in Sun Pharma, NTPC, Union Bank and Indian Bank

Institutional holding shows who is backing these promoter backed five-year winner stocks alongside the promoter. The table uses the latest reported quarter for each. NTPC has the deepest institutional backing, with FII and DII together holding 45.74% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%) and NTPC (from 28.92% to 29.44%).

Stock	Promoter	FII	DII	Public	Quarter
Sun Pharma	52.68%	14.36%	22.27%	10.70%	September 2026
NTPC	51.10%	16.30%	29.44%	3.15%	June 2026
Union Bank	74.76%	8.63%	11.98%	4.63%	June 2026
Indian Bank	73.84%	6.86%	16.77%	2.53%	September 2026

Risks to Weigh in Promoter Backed Five-Year Winner Stocks

Being careful with promoter backed five-year winner stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: A low PE can also reflect slower growth, so compare each PE with the growth rate instead of reading it alone.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Promoter Backed Five-Year Winner Stocks

Picking from promoter backed five-year winner stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.02 to 36.42) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Sun Pharma, NTPC, Union Bank and Indian Bank live prices.

Conclusion

Among promoter backed five-year winner stocks, Sun Pharma stands out for the largest market cap at Rs 4,27,161 crore, NTPC for 6.94% revenue growth in the June 2026 quarter, Union Bank for the fastest profit growth, 37.80% a year since FY22 and Indian Bank for the highest return on equity at 16.02%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing promoter backed five-year winner stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Promoter Backed Five-Year Winner Stocks to Watch

Which are the best promoter backed five-year winner stocks to watch for multibagger potential?

Ans. Sun Pharma, NTPC, Union Bank and Indian Bank are the 4 names this list highlights, with market caps of Rs 4,27,161 crore, Rs 3,18,210 crore, Rs 1,34,103 crore and Rs 1,13,970 crore respectively. Sun Pharma is notable for the largest market cap at Rs 4,27,161 crore. NTPC stands out for 6.94% revenue growth in the June 2026 quarter. Union Bank offers the fastest profit growth, 37.80% a year since FY22. Indian Bank brings the highest return on equity at 16.02%. These are watchlist names for promoter backed five-year winner stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Indian Bank a good stock for long-term investors?

Ans. Indian Bank has a return on equity of 16.02%, a PE of 8.62 against an industry PE of 12.02 and a market cap of Rs 1,13,970 crore. Net profit has compounded at 32.28% a year since FY22, and FY26 revenue rose 8.72% while September 2026 quarter net profit grew 13.36%. Long-term returns in promoter backed five-year winner stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Union Bank become a multibagger from here?

Ans. Union Bank has already gained 249.43% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in promoter backed five-year winner stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 37.80% a year since FY22, and FY26 revenue rose 0.19%. At a PE of 6.50 against an industry PE of 12.02, valuation should be checked against that growth before investing.

What is the market cap of Sun Pharma, NTPC, Union Bank and Indian Bank?

Ans. As of 30 October 2026, Sun Pharma has a market cap of Rs 4,27,161 crore, NTPC has a market cap of Rs 3,18,210 crore, Union Bank has a market cap of Rs 1,34,103 crore and Indian Bank has a market cap of Rs 1,13,970 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on promoter backed five-year winner stocks.

What are the risks of investing in promoter backed five-year winner stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Comparing each PE with growth gives a fuller picture than the PE alone.

Is Union Bank trading below its industry PE?

Ans. Union Bank trades at a PE of 6.50 against an industry PE of 12.02. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (net profit has compounded at 37.80% a year since FY22 and FY26 revenue rose 0.19%) and balance sheet strength before drawing a conclusion.

How much do institutions hold in Sun Pharma, NTPC, Union Bank and Indian Bank?

Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 45.74% of NTPC (16.30% and 29.44%), 20.61% of Union Bank (8.63% and 11.98%) and 23.63% of Indian Bank (6.86% and 16.77%). Rising institutional holding is a useful signal in promoter backed five-year winner stocks, though it should be read with earnings trends rather than on its own.